Skip to main content
    C

    CytomX Therapeutics Inc (CTMX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.94
    -0.04 (-2.27%)

    Market Cap: $444.73M

    Last updated: Nov 17, 2026 at 4:34 PM ET

    CytomX Therapeutics Inc (CTMX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    CytomX Therapeutics (CTMX) has a latest price of $1.94 on Nov 17, 2026, 76.4% below its 52-week high of $8.21. Its price fell 50.0% over the past 12 months. The month-end price fell 79.2% over the 10 years through Oct 2026, a compound annual decline of 14.5%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $29.71 in Feb 2018 and its lowest $0.64 in Mar 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart CTMX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CTMX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 45.7%, and over 6 months it fell 46.7%. The month-end price rose 112.7% over the 3 years through Oct 2026, a compound annual rate of 28.6%.

    PeriodChange
    1 month-17.1%
    3 months-45.7%
    6 months-46.7%
    12 months-50.0%
    12 months, with dividends-50.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+112.7%+28.6%
    5 years-60.5%-17.0%
    10 years-79.2%-14.5%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 313.6%, and its weakest was 2022, when it fell 63.0%.

    YearCloseChange
    2026 through Oct 2026$2.34-45.1%
    2025$4.26+313.6%
    2024$1.03-33.5%
    2023$1.55-3.1%
    2022$1.60-63.0%
    2021$4.33-33.9%
    2020$6.55-21.2%
    2019$8.31-45.0%
    2018$15.10-28.5%
    2017$21.11+92.1%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 22.3% below its 50-day average of $2.50 and 47.1% below its 200-day average of $3.67.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.94
    52-week high$8.21-76.4%
    52-week low$1.90+2.1%
    50-day average$2.50-22.3%
    200-day average$3.67-47.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 91.6%.

    MeasureValue
    1-year beta1.53
    Largest fall, 1 year-71.3%
    Largest fall, 3 years-91.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About CTMX

    What is CTMX's 1-year price change?

    CytomX Therapeutics's price fell 50.0% over the past 12 months. With dividends included, the 12-month total return was -50.0%.

    What is CTMX's 5-year price change?

    CytomX Therapeutics's month-end price fell 60.5% over the 5 years through Oct 2026, a compound annual decline of 17.0%. These figures leave out dividends.

    What is CTMX's 52-week high and low?

    CytomX Therapeutics's 52-week high is $8.21 and its 52-week low is $1.90. Its latest price of $1.94 on Nov 17, 2026 is 76.4% below the high.

    What is CTMX's beta?

    CytomX Therapeutics's 1-year beta against the S&P 500 is 1.53, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 71.3%.

    Is the CTMX chart free?

    Yes. Advanced Charting for CTMX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.